Article
VALIDATION OF A PANEL OF BIOMARKERS ASSOCIATED WITH AGGRESSIVE PHENOTYPE OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM.
Experimental oncology - 1 Nov 2022
Buchynska L G, Iurchenko N P, Nesina I P, Glushchenko N M
Abstract excerpt
AIM: To evaluate the prognostic significance of a panel of biomarkers for the identification of a highly malignant molecular subtype of endometrioid carcinoma of the endometrium (ECE). MATERIALS AND METHODS: The expression of a number of markers (CD24, CD44, E2F1, FOXP3, Her2/neu, p21WAF1/CIP1, p53, β-catenin, vimentin, Е-cadherin, с-Myc, cyclins D1 and Е1) was determined by the immunohistochemical method in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
